Gautam Kumar

1.0k total citations · 1 hit paper
35 papers, 687 citations indexed

About

Gautam Kumar is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Gautam Kumar has authored 35 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Infectious Diseases and 8 papers in Organic Chemistry. Recurrent topics in Gautam Kumar's work include Synthesis and biological activity (7 papers), Tuberculosis Research and Epidemiology (6 papers) and Antibiotic Resistance in Bacteria (6 papers). Gautam Kumar is often cited by papers focused on Synthesis and biological activity (7 papers), Tuberculosis Research and Epidemiology (6 papers) and Antibiotic Resistance in Bacteria (6 papers). Gautam Kumar collaborates with scholars based in India, Switzerland and Canada. Gautam Kumar's co-authors include B.M. Vrushabendra Swamy, C. K. Ashok Kumar, K. N. Jayaveera, Sanjay M. Jachak, Dharmarajan Sriram, Vagolu Siva Krishna, Shobhna Kapoor, Jitendra Patel, K. Rangarajan and Santonu Sarkar and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Journal of Medicinal Chemistry.

In The Last Decade

Gautam Kumar

33 papers receiving 611 citations

Hit Papers

Cancer multidrug-resistance reversal by ABCB1 inhibition:... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gautam Kumar India 14 211 128 127 86 86 35 687
Kiran Bharat Lokhande India 16 289 1.4× 74 0.6× 111 0.9× 94 1.1× 41 0.5× 62 653
Thiago Belarmino de Souza Brazil 15 177 0.8× 110 0.9× 223 1.8× 74 0.9× 93 1.1× 49 603
Mohd Danishuddin India 17 478 2.3× 83 0.6× 146 1.1× 80 0.9× 87 1.0× 39 1.1k
Fabrizia Brisdelli Italy 18 354 1.7× 147 1.1× 75 0.6× 68 0.8× 54 0.6× 46 943
Béatrice Marquez Belgium 11 315 1.5× 165 1.3× 120 0.9× 124 1.4× 140 1.6× 12 828
M. Obayed Ullah Bangladesh 12 254 1.2× 150 1.2× 56 0.4× 88 1.0× 99 1.2× 27 859
Tanuja Joshi India 16 231 1.1× 107 0.8× 106 0.8× 140 1.6× 58 0.7× 38 855
Gobindo Kumar Paul Bangladesh 15 341 1.6× 174 1.4× 88 0.7× 124 1.4× 99 1.2× 35 811
Ramakrishna Vadde India 19 430 2.0× 206 1.6× 105 0.8× 173 2.0× 76 0.9× 52 1.1k
Shopnil Akash Bangladesh 19 469 2.2× 117 0.9× 165 1.3× 95 1.1× 44 0.5× 91 1.2k

Countries citing papers authored by Gautam Kumar

Since Specialization
Citations

This map shows the geographic impact of Gautam Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gautam Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gautam Kumar more than expected).

Fields of papers citing papers by Gautam Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gautam Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gautam Kumar. The network helps show where Gautam Kumar may publish in the future.

Co-authorship network of co-authors of Gautam Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Gautam Kumar. A scholar is included among the top collaborators of Gautam Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gautam Kumar. Gautam Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Gautam, et al.. (2025). Combating Multi-drug Resistant Mycobacterium Species by Efflux Pump Inhibitors: Contemporary Trends. SHILAP Revista de lepidopterología. 6(1).
2.
Kumar, Gautam, et al.. (2025). Indotropane Pseudo-Natural product is a novel class of potent and selective antibacterial agent against methicillin- and vancomycin-resistant S. aureus. European Journal of Medicinal Chemistry. 296. 117805–117805. 1 indexed citations
3.
Kumar, Gautam, et al.. (2024). Tackling multi-drug resistant fungi by efflux pump inhibitors. Biochemical Pharmacology. 226. 116400–116400. 10 indexed citations
4.
Kumar, Gautam, et al.. (2024). Biaryl carboxamide‐based peptidomimetics analogs as potential pancreatic lipase inhibitors for treating obesity. Archiv der Pharmazie. 357(4). e2300503–e2300503. 8 indexed citations
5.
Thirupathi, Nuligonda, et al.. (2024). An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations. Nature Communications. 15(1). 7080–7080. 4 indexed citations
6.
Kumar, Gautam, et al.. (2024). Tackling Influenza A virus by M2 ion channel blockers: Latest progress and limitations. European Journal of Medicinal Chemistry. 267. 116172–116172. 26 indexed citations
7.
Kumar, Gautam, et al.. (2024). Identification and Benchmarking of Myokinasib-II as a Selective and Potent Chemical Probe for Exploring MLCK1 Inhibition. ACS Chemical Biology. 19(10). 2165–2175. 4 indexed citations
10.
Kumar, Gautam, et al.. (2023). Efflux pump inhibitory potential of indole derivatives as an arsenal against norA over-expressing Staphylococcus aureus. Microbiology Spectrum. 11(5). e0487622–e0487622. 18 indexed citations
11.
Kumar, Gautam, et al.. (2023). Tackling multidrug-resistant Staphylococcus aureus by natural products and their analogues acting as NorA efflux pump inhibitors. Bioorganic & Medicinal Chemistry. 80. 117187–117187. 26 indexed citations
12.
Kumar, Gautam & Shobhna Kapoor. (2023). Targeting mycobacterial membranes and membrane proteins: Progress and limitations. Bioorganic & Medicinal Chemistry. 81. 117212–117212. 17 indexed citations
13.
Kumar, Gautam, et al.. (2023). Natural products acting against S. aureus through membrane and cell wall disruption. Natural Product Reports. 40(10). 1608–1646. 31 indexed citations
14.
Kumar, Gautam, et al.. (2023). TargetingMycobacterium tuberculosisiron-scavenging tools: a recent update on siderophores inhibitors. RSC Medicinal Chemistry. 14(10). 1885–1913. 6 indexed citations
15.
Kumar, Gautam, et al.. (2022). Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update. European Journal of Medicinal Chemistry. 239. 114542–114542. 135 indexed citations breakdown →
17.
Kumar, Gautam, Vagolu Siva Krishna, Dharmarajan Sriram, & Sanjay M. Jachak. (2020). Pyrazole–coumarin and pyrazole–quinoline chalcones as potential antitubercular agents. Archiv der Pharmazie. 353(8). e2000077–e2000077. 49 indexed citations
18.
Kumar, Gautam, Rishikesh Narayan, & Shobhna Kapoor. (2020). Chemical Tools for Illumination of Tuberculosis Biology, Virulence Mechanisms, and Diagnosis. Journal of Medicinal Chemistry. 63(24). 15308–15332. 13 indexed citations
19.
Kumar, Gautam, Vagolu Siva Krishna, Dharmarajan Sriram, & Sanjay M. Jachak. (2018). Synthesis of carbohydrazides and carboxamides as anti-tubercular agents. European Journal of Medicinal Chemistry. 156. 871–884. 16 indexed citations
20.
Kumar, Gautam, et al.. (2018). Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents. European Journal of Medicinal Chemistry. 157. 1–13. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026